Global Fertility Supplement Market
Fertility supplements contain micronutrients, which are vitamins and minerals that the human body needs in small amounts. Some people (male or female) may take these supplements to increase their chances of a healthy pregnancy. Majorly supplements are playing significant roles in women’s reproductive health and are essential for many functions, including menstruation and ovulation, thyroid function, and egg quality and maturation.
Market Size & Growth Rate:
The fertility supplement market was valued at USD 1.72 billion in 2021 and is expected to reach USD 7.54 billion by 2027, and is projected to expand at a CAGR of 7.8% during the forecast period 2022-2027. Due to significant research & development, the launches of new supplements, extensive research, low infertility rate, and favorable reimbursement scenario are anticipated to propel the global fertility supplement market.
Market Dynamics:
Fertility supplements, like all nutritional supplements, are not regulated by the FDA or any other regulating body. It means that no one is keeping track of what’s in these supplements. However, according to CDC (December 2021) report, In the United States, 14.1% of married women between the ages of 15 and 49 had impaired fertility, while 13.1% of women had impaired fertility, and 6% of married women were found to be infertile.
In addition, the PRB (August 2021) published data, which has observed that the fertility rate for women of all age groups in the majority of countries is gradually decreasing for women of all age groups.
Furthermore, according to the WHO, infertility has become common due to various factors such as an increase in alcohol consumption, smoking, an increased number of obese people, increased stress levels causing hormonal imbalance, and other factors.
Thus, the declining fertility rate among women and an increasing number of infertile males are increasing the demand for fertility supplements which is expected to propel the growth of the fertility supplement market in the forecast period.
Market Drivers:
-
Increased the demand for fertility supplements (like Folic Acid, Vitamin-E, Acetyl L-carnitine).
-
Fertility supplements have been found to help increase fertility rates, promote healthy pregnancy and ovulation, and improve delivery by improving hormonal profiles.
-
According to the American society for reproductive medicine, the male partner is responsible for infertility in roughly 40% of infertile couples, and approximately 80%–90% of these couples are treated with pharmaceutical products including fertility supplements products. For instance,
-
Folic acid improves blood flow and prevents elevated blood pressure, and during pregnancy, it minimizes the risk of abnormalities for the baby, such as neural tube defects (failure of the spine or brain formation). So for many reasons, it is a good supplement to start supplementing with folic acid in advance. It can be taken separately or as part of a prenatal vitamin. According to Mark trolice (The IVF Center), all women even if they are not trying to conceive should take 400 mg of folic acid daily. However, pregnant women and those trying to conceive can take up to 1 mg daily.
-
Moreover, Zinc, vitamins C, D, E, Omega 3, and others, as these supplements are correlated with male and female infertility, most of the population across the globe is inclined toward fertility supplements as they are a good source of micronutrients and help in fertility.
-
Rising demand for herbal fertility supplements.
-
The prevalence of smoking is higher in developed countries.
-
Increasing Infertility rate.
Challenges:
-
The high price of supplements restrains the market growth
-
The increasing price of fertility supplements is expected to restrain the growth of the market and rising consumer inclination towards organic products and the limited availability of organic supplements can future hamper the market growth.
-
However, supplement manufacturers are focusing on technological advancement to minimize production costs the make products available for the consumer at affordable prices.
-
China's fertility drop lowers the world growth rate
-
Limited availability of organic supplements
-
Lack of awareness among the population of low-income economies
Competitive Landscape:
Fairhaven Health, Coast Science, Lenus Pharma GesmbH, Active Bio Life Science GmbH, Orthomol, Exeltis USA, Inc., PregPrep LLC, Bionova, TTK HealthCare Ltd., Fertility Nutraceuticals LLC, Vitabiotics Ltd., Extreme V, Inc., VH Nutrition LLC, CellOxess LLC, Gonadosan, Amino Expert (Innovamed Ltd.), Babystart Ltd., Crown Nutraceuticals, Sal Nature, YadTech
Key Developments:
Competitors in the global fertility supplement market are engaged in regulatory approvals, the development of new services, and acquisition & collaborative agreements with other companies. A few expansion strategies are adopted by players operating in the fertility supplement market.
-
In February 2022, EMD Serono, the healthcare business of Merck KGaA, launched slim pack fertility medication packaging, reduced in size for convenience. This new footprint improves portability, efficiency, and convenience.
-
In March 2022, Dadi (sperm collection as well as testing startup-2019), was acquired by online pharmacy Ro for approximately USD 100 million. With this acquisition, the company expands its presence in the fertility supplement markets
-
In April 2022, Ovaterra by Fertility Nutraceuticals launched two new vitamin supplements. They are parental supplemental capsules formulated with the full recommended daily value of choline for pregnant and nursing women.
-
In April 2022, Wellbeing Nutrition introduced SLOW, a time-conscious line of supplements for both women and men. It consists of 13 supplements, designed purely for various types of health needs including fertility support.
-
In August 2020, Amazon launched an online pharmacy in Bangalore, India, with the increasing demand faced by online channels
Regional Analysis:
North America is expected to witness significant growth over the forecast period due to the increasing infertility rate among people and rising awareness among the population about overall health.
According to the WHO, infertility is a common problem due to various significant factors that influence it, such as increased alcohol and drug use, higher levels of stress (hormonal imbalances), obesity, environmental factors, and frequent smoking among the main causes of the rise in infertility rates, which will fuel the demand for fertility supplements. In addition, the prevalence of smoking is higher in developed countries than in emerging economies, which has prompted fertility supplements to enhance ingredients that can eliminate the effects of smoking on fertility.
In January 2022, the US HHS announced data that 40.5% of males over the age of 20 years are obese, 15.3% of men over the age of 18 years smoke frequently, 30.9% of men over the age of 18 years consumed five or more drinks in a single day, and 51.9% of men over the age of 20 years have hypertension in the United States. These factors are anticipated to create growth opportunities for fertility supplement manufacturers over the forecast period.
Europe is driven by the rapidly rising geriatric population, followed by increased consumer interest and awareness of dietary supplements. The market is anticipated to witness substantial growth in emerging economies. In addition, the growing importance of food products such as olive oil, whole grains, avocados, and high-fat dairy products to increase fertility is predicted to expand the market for functional foods and beverages in the near future, which may slow overall industry growth.
However, growing consumer anxiety over the negative side effects of pharmaceutical products is expected to increase the use of supplements, which will benefit product manufacturers.
Moreover, the market in Germany, France, and the UK is expected to grow rapidly due to increased initiatives by the government and nonprofit organizations to raise awareness about fertility medication and treatment and the rising rate of obesity and sexually transmitted infections.
These factors reflect to demand for fertility supplements is also anticipated to increase over the forecast period due to self-medication, cost efficiency, and convenience of direct purchase.
Asia-Pacific is expected significant opportunities for key players operating in the fertility supplement market. The region offers extensive opportunities for leading key companies in the fertility supplement market due to the increased availability and accessibility of healthcare facilities and increased expenditure in research and healthcare platforms. Rising nutritional enrichment awareness in Japan, India, and China is anticipated to be a significant factor in regional growth. Furthermore, the expansion of the retail market in various countries such as India, China, Indonesia, and Malaysia as a result of regulatory support to encourage investment is expected to increase buyer accessibility over the forecast period, which will help the market grow in the region.
In addition, government initiatives such as "one child per couple," which involved forced sterilizations or abortions, reduced women's fertility. However, it is anticipated that the elimination of the one- or two-child per couple policies and significant changes to family planning laws will positively impact fertility rates. This is one of the elements anticipated to hamper market expansion in China.
South America market has been witnessing substantial growth in the past few years, attributed to a series of factors, including the rising middle-class population, increasing adoption of healthcare lifestyle among the population, and rising product launches across the region. In countries such as Brazil and Argentina, along with traditional supplements, the demand for herbal supplements is also growing at a speedy footstep, which positively impacts factors for the growth of the market.
MEA countries such as South Africa, UAE, Saudi Arabia, and others, the increasing consumer desirability to reduce their risk of illness and increasing healthcare are predicted to support the market growth. And raise awareness to the market players distributing free fertility supplements products for educating the people and promoting their enriched supplements is anticipated to propel the fertility supplements market during the forecast period.
Segmentation:
-
The global short bowel syndrome market estimates (Value USD Million) & Forecasts and Trend Analyses, 2022 to 2027 based on Ingredient
-
Natural
-
Synthetic/Blend of Natural & Synthetic
-
The global short bowel syndrome market estimates (Value USD Million) & Forecasts and Trend Analyses, 2022 to 2027 based on Product
-
Capsule
-
Tablets
-
Soft Gels
-
Powders
-
Liquids
What is the Fertility Supplements Market Report about?
The fertility supplements market report discusses the commercial and clinical activity associated with applications. It provides insights on the total size of the potential opportunity, key segments driving growth, key challenges faced, and a thorough analysis of market competition by product, geography, indication, and forecasts through 2027. Detailed coverage of the approved fertility supplements including product launching, pricing, and market penetration.
So, a new investor can potentially gain information about fertility supplement companies, their key products, their core strategy, key trends in the fertility supplements market, and more.
The fertility supplements market report is essential for all stakeholders including research companies, manufacturing companies, distribution companies, government agencies, and others.
-
Capitalize on rapidly emerging trends
-
Optimize decision-making
-
Reduce company risk
-
Approach partners/investors for collaboration or funding
-
Implement an informed and advantageous business strategy in 2022
-
Detailed coverage of the approved fertility supplement products, including regulatory approvals, pricing, reimbursement, and market penetration
-
Profiles of leading & upcoming fertility supplements competitors composing the global marketplace